JohnBBuseMD

PubMed

• 46 citations
  Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Ris...
  Denise E. Bonds, Timothy E. Craven, John B. Buse, John R. Crouse, R. Cuddihy
  Diabetologia. 2012-03-27
• 150 citations
  Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: A randomized clinical trial
  Steven E. Nissen, Kathy Wolski, Lisa Prcela, Thomas A. Wadden, John B. Buse
  JAMA. 2016-03-08
• 1203 citations
  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
  Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann
  The New England Journal of Medicine. 2016-07-28

Journal Articles

• Improved Time in Range and Glycemic Variability with Sotagliflozin in Combination with Insulin in Adults with Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous ...  
  Jake A Kushner, John B Buse, Satish K Garg, Darren K McGuire, Diabetes Care
• Lower Rates of Cardiovascular Events and Mortality Associated with Liraglutide Use in Patients Treated with Basal Insulin – A DEVOTE Subanalysis (DEVOTE 10)  
  John B Buse, Darren K McGuire, Richard E Pratley, Diabetes, Obesity and Metabolism
• Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes  
  Sims EK, Bahnson HT, Nyalwidhe J, Haataja L, Davis AK, Speake C, DiMeglio LA, Blum J, Morris MA, Mirmira RG, Nadler J, Mastracci TL, Marcovina S, Qian WJ, Yi L, Swense..., Diabetes Care, 1/1/2019
• The Impact of Metformin Use on the Cardiovascular Effects of DPP‐4 Inhibitors: An Analysis of Medicare Claims Data 2007‐2015  
  John B Buse, Matthew J Crowley, Virginia Pate, Diabetes, Obesity and Metabolism
• Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes  
  Vasilios Papademetriou, Lois Katz, John B Buse, Amy K Mottl, Carolyn F Pedley, Debra L Simmons, Journal of the American Society of Nephrology
• Health‐Related Quality of Life in People with Type 2 Diabetes Participating in the LEADER Trial  
  John Buse, MD, Diabetes, Obesity and Metabolism
• Fast‐Acting Insulin Aspart Versus Insulin Aspart in the Setting of Insulin Degludec‐Treated Type 1 Diabetes: Efficacy and Safety from a Randomized Double‐Blind Trial  
  John B Buse, Anders L Carlson, Diabetes, Obesity and Metabolism
• The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients with Type 2 Diabetes at High Risk for Cardiovascular Events: Res...  
  John B Buse, Richard E Pratley, Diabetes Care
• Management of Type 1 Diabetes with a Very Low–Carbohydrate Diet: A Word of Caution  
  John Buse, MD, AAP News
• Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults  
  Seema Garg, John B Buse, Virginia Pate, Diabetes Care
• Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?  
  John Buse, MD, Diabetes Care
• Sotagliflozin in Combination with Optimized Insulin Therapy in Adults with Type 1 Diabetes: The North American inTandem1 Study  
  Satish K Garg, John B Buse, Jake A Kushner, Darren K McGuire, Diabetes Care
• Comparative Effectiveness of Canagliflozin, SGLT2 Inhibitors and Non‐SGLT2 Inhibitors on the Risk of Hospitalization for Heart Failure and Amputation in Patients with ...  
  John Buse, MD, Diabetes, Obesity and Metabolism
• Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Acute Coronary Syndrome  
  John B Buse, Gregory G Schwartz, Diabetes Care
• Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience  
  Steven P Marso, John B Buse, Diabetes Care
• Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes and Moderate Renal Impairment (Chronic Kidney Disease Stage 3A): The DERIVE Study  
  John Buse, MD, Diabetes, Obesity and Metabolism
• Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes  
  Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group., N Engl J Med., 1/1/2017
• Prevalence of Celiac Disease in 52,721 Youth With Type 1 Diabetes: International Comparison Across Three Continents  
  Craig ME, Prinz N, Boyle CT, Campbell FM, Jones TW, Hofer SE, Simmons JH, Holman N, Tham E, Fr�hlich-Reiterer E, DuBose S, Thornton H, King B, Maahs DM, Holl RW, Warne..., Diabetes Care, 1/1/2017
• Pioglitazone after Ischemic Stroke or Transient Ischemic Attack  
  Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, Brass LM, Schwartz GG, Adams HP Jr, Berger L, Carolei A..., N Engl J Med, 1/1/2016
• Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes  
  Fulcher G, Matthews DR, Perkovic V, de Zeeuw D, Mahaffey KW, Mathieu C, Woo V, Wysham C, Capuano G, Desai M, Shaw W, Vercruysse F, Meininger G, Neal B; CANVAS trial co..., Diabetes Obes Metab, 1/1/2016
• IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test  
  Holst JJ, Buse JB, Rodbard HW, Linjawi S, Woo VC, Boesgaard TW, Kvist K, Gough SC., J Diabetes Sci Technol., 1/1/2016
• Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States  
  DuBose SN, Hermann JM, Tamborlane WV, Beck RW, Dost A, DiMeglio LA, Schwab KO, Holl RW, Hofer SE, Maahs DM; Type 1 Diabetes Exchange Clinic Network and Diabetes Prospe..., J Pediatr., 1/1/2015
• Racial-ethnic disparities in management and outcomes among children with type 1 diabetes  
  Willi SM, Miller KM, DiMeglio LA, Klingensmith GJ, Simmons JH, Tamborlane WV, Nadeau KJ, Kittelsrud JM, Huckfeldt P, Beck RW, Lipman TH; T1D Exchange Clinic Network., Pediatrics, 1/1/2015
• Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions  
  Espeland MA, Probstfield J, Hire D, Redmon JB, Evans GW, Coday M, Lewis CE, Johnson KC, Wilmoth S, Bahnson J, Dulin MF, Green JB, Knowler WC, Kitabchi A, Murillo AL, O..., Am J Hypertens, 1/1/2015
• Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease  
  Yale JF, Bakris G, Cariou B, Nieto J, David-Neto E, Yue D, Wajs E, Figueroa K, Jiang J, Law G, Usiskin K, Meininger G; DIA3004 Study Group., Diabetes Obes Metab., 1/1/2014
• Join now to see all

Books/Book Chapters

• Williams Textbook of Endocrinology 
  Chapter: Type 2 diabetes mellitus. 
  Page 1371. - 1435.Buse JB, Polonsky KS, Burant CFEditors: S Melmed, KS Polonsky, PR Larsen, HM Kronenberg.Saunders Elsevier Science, Philadelphia, PAEdition 12th,2012
• Williams Textbook of Endocrinology 
  Chapter: Type 1 diabetes mellitus. 
  Page 1436. - 1461.Eisenbarth GS and Buse JBEditors: S Melmed, KS Polonsky, PR Larsen, HM Kronenberg.Saunders Elsevier Science, Philadelphia, PAEdition 12th,2012
• Evidence-Based Management of Diabetes 
  Editors: Vora J and Buse J.TFM Publishing Limited, Shrewsbury, UK2012
• Endocrinology 
  Chapter: Management of type 2 diabetes mellitus. 
  Page 897.0 - 915.0Dungan KM and Buse JBEditors: J. Larry Jameson and Leslie J DeGroot.Saunders Elsevier, Philadelphia, PAEdition 6th,2011
• Medical Management of Type 2 Diabetes 
  American Diabetes Association (J Buse, contributing editor)Editors: Charles F. Burant.American Diabetes AssociationEdition 6th,2009
• The Uncomplicated Guide to Diabetes Complications 
  Chapter: Diabetes standards of care 
  Page 16.0 - 25.0Buse JBEditors: ME Levin and MA Pfeifer.American Diabetes Association, Alexandria, VAEdition 3rd,2009
• Educational Review Manual in Endocrinology, Diabetes and Metabolism, Focus: Diabetes 
  Chapter: Diabetes and cardiovascular disease � the impact of glycemic control. 
  Page 229.0 - 242.0Kendall DM and Buse JBEditors: DM Kendall and RM Bergenstal.Castle Connolly Graduate Medical Publishing, New York, NYEdition 3rd,2009
• Educational Review Manual in Endocrinology, Diabetes and Metabolism, Focus: Diabetes 
  Chapter: Pre-diabetes and the prevention of diabetes 
  Page 289.0 - 298.0Solum AM, Buse JB, O�Connell TEditors: DM Kendall and RM Bergenstal.Castle Connolly Graduate Medical Publishing, New York, NYEdition 3rd,2009
• Williams Textbook of Endocrinology 
  Chapter: Type 2 diabetes mellitus 
  Page 1329. - 1389.Buse JB, Polonsky KS, Burant CF.Editors: HM Kronenberg, S Melmed, KS Polonsky, PR Larsen.Elsevier Science, Philadelphia, PAEdition 11th,2008
• Williams Textbook of Endocrinology 
  Chapter: Type 1 diabetes mellitus 
  Page 1391. - 1416.Eisenbarth GS, Polonsky KS, Buse JBEditors: HM Kronenberg, S Melmed, KS Polonsky, PR Larsen.Elsevier Science, Philadelphia, PAEdition 11th,2008
• Clinical Diabetes: Translating Research into Practice 
  Chapter: Scope of the problem: The diabetes-metabolic epidemic. 
  Buse JBEditors: Vivian Fonseca.Saunders, Philadelphia, PAEdition 1.0,2006
• UpToDate 
  Chapter: Amylin and GLP-1-based therapies for the treatment of diabetes 
  Dungan K and Buse J.Editors: Rose, BD.UpToDate, Wellesley, MA2005
• Principles of Critical Care Medicine 
  Chapter: Ketoacidosis, HONKC and hypoglycemia. 
  Page 1209. - 1217.Buse JB and Polonsky KS.Editors: JB Hall, GA Schmidt, LDH Woods.McGraw Hill, New York, NYEdition 3rd,2005
• Conn�s Current Therapy 
  Chapter: Diabetes mellitus in adults 
  Page 661.0 - 670.0Buse JBEditors: Robert E Rakel and Edward T Bope.Saunders, Philadelphia, PA2005
• The Cadre Handbook of Diabetes Management 
  Chapter: Rationale for standards of care. 
  Page 29.0 - 51.0Buse JBEditors: WT Cefalu, JE Gerich, D LeRoith.Medical Information Press, New York, NY2004
• Medical Management of Type 2 Diabetes 
  American Diabetes Association (J Buse, contributing editor)Editors: Charles F. Burant.American Diabetes AssociationEdition 5th,2004
• Netter�s Internal Medicine 
  Chapter: Diabetes mellitus and its complications. 
  Page 184.0 - 194.0Buse JBEditors: MS Runge and MA Greganti.Icon Learning Systems LLC, Teterboro, NJ2003
• Insulin Resistance Syndrome 
  Page 7.0 - 10.0Buse JBBlackwell Science, Oxford, UK2000
• Management of Office Emergencies 
  Chapter: The Patient with Diabetes 
  Page 73.0 - 95.0Buse JBEditors: C.W. Barton.McGraw Hill, New York1999
• Therapy for Diabetes Mellitus and Related Disorders 
  Chapter: Monitoring Diabetes 
  Page 109.0 - 117.0Nathan DM and Buse JBEditors: H Lebovitz.American Diabetes Association, Alexandria, VAEdition 3rd,1998
• Medical Management of Type 2 Diabetes 
  Buse JB, contributing editorEditors: B Zimmerman.American Diabetes Association, Alexandria, VAEdition 4th,1998
• Principles of Critical Care Medicine 
  Chapter: Diabetic ketoacidosis, hyperglycemic hyperosmolar nonketotic coma, and hypoglycemia. 
  Page 1183. - 1193.Buse JB and Polonsky KSEditors: JB Hall, GA Schmidt, LDH Woods.McGraw Hill, New YorkEdition 2nd,1998
• Manual of Clinical Problems in Adult Ambulatory Care 
  Chapter: Management of Complications of Diabetes 
  Page 371.0 - 375.0Doerr ME and Buse JBEditors: L Dornbrand, AJ Hoole, RH Fletcher.Lippincott-Raven Publishers, PhiladelphiaEdition 3rd,1997
• Manual of Clinical Problems in Adult Ambulatory Care 
  Chapter: Management of Type II Diabetes. 
  Page 364.0 - 371.0Doerr ME and Buse JBEditors: L Dornbrand, AJ Hoole, RH Fletcher.Lippincott-Raven Publishers, PhiladelphiaEdition 3rd,1997
• Conn's Current Therapy 
  Chapter: Diabetic Ketoacidosis 
  Page 553.0 - 537.0Buse JB and Doerr MEEditors: RE Rakel.W.B. Saunders Co., Philadelphia, PA1997
• Join now to see all

Lectures

• For Debate: A Reasonable A1C Goal for Many Nonpregnant Adults is <7% (53 mmol/mol) 
  ENDO 2019 - New Orleans, LA - 3/23/2019
• Neoplasms Reported with Liraglutide or Placebo in People with Type 2 Diabetes: Results from the LEADER Randomized Trial 
  Chapel Hill, NC - 6/15/2014
• Duke Regional Diabetes Symposium 2012 
  Duke University School of Medicine, Kannapolis, North Carolina - 7/13/2012

Other

• Consensus Development Conference on Pramlintide in the Management of Type 1 and Type 2 Diabetes 
  Hirsch IB, Blonde L, Buse J, Close K, Edelman SV, Peters A, Valentine V, Wysham C, Garg S, The Diabetes Education Group
  Lakeville, CT - 1/1/2006
• A practical approach to the management of type 2 diabetes in the context of cardiovascular risk. 
  Buse JB, Henry RR, Pri-Med in Practice
  Boston, MA - 1/1/2006
• Management of Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State in Adults. 
  JB Buse, M Menke, TS Sisca, Scherer Clinical Communication
  1/1/2005
• Diabetes Treatment: Focus on Postprandial Glucose 
  Buse JB, Postprandial Hyperglycemia in Type Diabetes.
  1/1/2002
• The Basics of Continuous Subcutaneous Insulin Infusion Therapy. 
  John B. Buse, Thomas S. Sisca, Jane Young, HealthAnswers, Inc.
  1/1/2002
• Metabolic Side Effects: Focus on Hyperglycemia and Diabetes. 
  Buse JB, JCP Visuals
  1/1/2002
• Recent findings: five epidemiological studies who comparable rates of diabetes among antipsychotic agents. 
  Buse JB., Clinical Perspectives in Psychiatry
  New York - 1/1/2002
• Diabetic Ketoacidosis in the Adult Patient 
  John B. Buse, Thomas S. Sisca, Marsha Menke, HealthAnswers, Inc.
  1/1/2002
• New treatment strategies for type 2 diabetes: Where are we now and where are we going? 
  Buse JB., Current Diabetes Care: The evolving role in the pharmacist and emerging treatment strategies
  New York, NY - 1/1/2001
• Lantus (insulin glargine). 
  American Pharmaceutical Association New Product Bulletin
  Washington, DC - 1/1/2000
• Myths Regarding Diabetes Care and Coronary Disease. 
  Buse JB., Lipid Nurse Task Force Newsletter
  Milwaukee, WI - 1/1/1999
• Advances in Diabetes Treatment - Implications for Lipid Management 
  Buse JB, Lipid Nurse Task Force Newsletter
  Milwaukee, WI - 1/1/1999
• Insulin Resistance: Role in the Clinical Management of Diabetes. 
  Buse JB., Pharmedica Communications
  Killingworth, CT - 1/1/1999
• Making Nutrition Work in the Management of Type 2 Diabetes: A Guide for Patients. 
  Buse JB and Bruntlett EQ.
  West Haven, CT - 1/1/1999
• Making Nutrition Work in the Management of Type 2 Diabetes: A Guide for Diabetes Care Providers. 
  Buse JB and Bruntlett EQ
  West Haven, CT - 1/1/1999
• Diabetic Emergencies. Acute Glycemic Control 
  Buse J, Patterns of Care: Guidelines for Diabetes Care.
  Raleigh, NC - 1/1/1999
• Diabetes Management. Long Term Glycemic Control. 
  Buse J and Yarborough P., Patterns of Care: Guidelines for Diabetes Care.
  Raleigh, NC - 1/1/1999
• The role of medical nutrition therapy in type 2 diabetes 
  Bruntlett E and Buse JB., Mediguide to Diabetes
  New York, NY - 1/1/1998
• Is there a role for cardiovascular risk factor reduction in pre-menopausal woman with diabetes? 
  Berlin C and Buse J., Lipid Nurse Task Force Newsletter
  Milwaukee, WI - 1/1/1998
• Review of Ralph DeFronzo's Current Therapy of Diabetes Mellitus. 
  Buse, JB, Annals of Internal Medicine
  1/1/1998
• Clinical Case Studies in Diabetes. Pearls and Pitfalls. A Focus on NIDDM. 
  Buse JB, Edelman SV, Knudson PE., Clinical Communications
  Greenwich, CT - 1/1/1997
• Postprandial hyperglycemia: Implications for NIDDM 
  Davidson JA, Lebovitz HE, Buse JB, Svec F.
  Killingworth, CT - 1/1/1997
• Clinical Case Studies in Diabetes. Pearls and Pitfalls. A Focus on NIDDM for the Specialist. 
  Buse JB, Edelman SV, Knudson PE., Clinical Communications
  Greenwich, CT - 1/1/1997
• Postprandial hyperglycemia: Implications for NIDDM. 
  Kahn C, Buse JB, Lebovitz HE, Nadeau D
  Killingworth, CT - 1/1/1997
• Ask the Expert: Risk of Hepatotoxicity with New Thiazolidinediones 
  Buse JB, Medscape Diabetes and Endocrinology
  http://www.medscape.com/viewarticle/412413
• Join now to see all